New search | Conferencedetail
Print view
 
 

7th Drug Formulation, Solubility and Bioavailability

evvnt Platform / evvnt
Conference themes
When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL's 7th Drug Formulation, Solubility and Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success.
Professional congress organizer (PCO)
Exl Events
Notes
Speakers: Rossitza Alargova Director, Formulations, INFINITY PHARMACEUTICALS, Gail Dempsey EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH, Rakesh Dixit Vice President, RandD, Global Head, Biologics Safety, MEDIMMUNE
 

Enquiries and Registration:

URLs: Brochure: https://go.evvnt.com/174423-1 Booking: https://go.evvnt.com/174423-2
Ms. Alysha Parker
 
Categories
Internal Medicine
Languages
English
Congress fees
USD 2.895,00
(Conference Only - Early Bird Pricing - Register by February 9, 2018: USD 1795, Conference + Seminar - Onsite Pricing: USD 2895)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

newTreeSwiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienFFG - 7. EU-RahmenprogrammCharité International AcademyHilfswerk AustriaÄrztekammer für WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation

Facebook

Give us your professional opinion

Start survey

Start survey